Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiliang Qiu

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Cancer Cell International|April 4, 2023
A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinomaZhu Lin, Zhenkun Huang, Yunxing Shi, et al.
Oncology Research|January 30, 2026
RNF145 Promotes Hepatocellular Carcinoma Metastasis through Ubiquitination and Degradation of PCDH9Huan Zhang, Zhangwendi Xu, Yien Xu, et al.
Annals of Surgery|July 3, 2015
Nomograms for Pre- and Postoperative Prediction of Long-term Survival for Patients Who Underwent Hepatectomy for Multiple Hepatocellular CarcinomasPinghua Yang, Jiliang Qiu, Jun Li, et al.
FEBS Open Bio|May 2, 2021
SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial-mesenchymal transitionYuanping Zhang, Jiliang Qiu, Dinglan Zuo, et al.
Cancer Reports (Hoboken, N.J.)|March 5, 2024
Nomograms to predict long-term survival for patients with gallbladder carcinoma after resectionShilei Bai, Pinghua Yang, Jiliang Qiu, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 28, 2012
Expression and prognostic significance of CIP2A mRNA in hepatocellular carcinoma and nontumoral liver tissuesPinzhu Huang, Jiliang Qiu, Jinghong You, et al.
Clinical and Experimental Medicine|June 28, 2024
PD-L1 inhibitor versus PD-1 inhibitor plus bevacizumab with transvascular intervention in unresectable hepatocellular carcinomaZhenkun Huang, Tiejun Chen, Wenbin Li, et al.
Journal of Translational Medicine|September 30, 2011
Identification of MACC1 as a novel prognostic marker in hepatocellular carcinomaJiliang Qiu, Pinzhu Huang, Qian Liu, et al.
International Immunopharmacology|July 19, 2024
Atezolizumab and bevacizumab plus transarterial chemoembolization and hepatic arterial infusion chemotherapy for patients with high tumor burden unresectable hepatocellular carcinoma: A multi-center cohort studyZhenkun Huang, Tiejun Chen, Wenbin Li, et al.
Clinical Biochemistry|March 8, 2011
Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomyPinzhu Huang, Jiliang Qiu, Binkui Li, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Cancer Cell International|April 4, 2023
A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinomaZhu Lin, Zhenkun Huang, Yunxing Shi, et al.
Oncology Research|January 30, 2026
RNF145 Promotes Hepatocellular Carcinoma Metastasis through Ubiquitination and Degradation of PCDH9Huan Zhang, Zhangwendi Xu, Yien Xu, et al.
Annals of Surgery|July 3, 2015
Nomograms for Pre- and Postoperative Prediction of Long-term Survival for Patients Who Underwent Hepatectomy for Multiple Hepatocellular CarcinomasPinghua Yang, Jiliang Qiu, Jun Li, et al.
FEBS Open Bio|May 2, 2021
SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial-mesenchymal transitionYuanping Zhang, Jiliang Qiu, Dinglan Zuo, et al.
Cancer Reports (Hoboken, N.J.)|March 5, 2024
Nomograms to predict long-term survival for patients with gallbladder carcinoma after resectionShilei Bai, Pinghua Yang, Jiliang Qiu, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 28, 2012
Expression and prognostic significance of CIP2A mRNA in hepatocellular carcinoma and nontumoral liver tissuesPinzhu Huang, Jiliang Qiu, Jinghong You, et al.
Clinical and Experimental Medicine|June 28, 2024
PD-L1 inhibitor versus PD-1 inhibitor plus bevacizumab with transvascular intervention in unresectable hepatocellular carcinomaZhenkun Huang, Tiejun Chen, Wenbin Li, et al.
Journal of Translational Medicine|September 30, 2011
Identification of MACC1 as a novel prognostic marker in hepatocellular carcinomaJiliang Qiu, Pinzhu Huang, Qian Liu, et al.
International Immunopharmacology|July 19, 2024
Atezolizumab and bevacizumab plus transarterial chemoembolization and hepatic arterial infusion chemotherapy for patients with high tumor burden unresectable hepatocellular carcinoma: A multi-center cohort studyZhenkun Huang, Tiejun Chen, Wenbin Li, et al.
Clinical Biochemistry|March 8, 2011
Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomyPinzhu Huang, Jiliang Qiu, Binkui Li, et al.
Pageof 8